700 related articles for article (PubMed ID: 27847966)
1. Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation.
Hsieh MJ; Liu HT; Wang CN; Huang HY; Lin Y; Ko YS; Wang JS; Chang VH; Pang JS
J Mol Med (Berl); 2017 Mar; 95(3):323-333. PubMed ID: 27847966
[TBL] [Abstract][Full Text] [Related]
2. Loss of osteoglycin promotes angiogenesis in limb ischaemia mouse models via modulation of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 signalling pathway.
Wu QH; Ma Y; Ruan CC; Yang Y; Liu XH; Ge Q; Kong LR; Zhang JW; Yan C; Gao PJ
Cardiovasc Res; 2017 Jan; 113(1):70-80. PubMed ID: 28069703
[TBL] [Abstract][Full Text] [Related]
3. Total Flavones of Abelmoschus manihot Exhibits Pro-Angiogenic Activity by Activating the VEGF-A/VEGFR2-PI3K/Akt Signaling Axis.
Zhu GS; Tang LY; Lv DL; Jiang M
Am J Chin Med; 2018; 46(3):567-583. PubMed ID: 29595071
[TBL] [Abstract][Full Text] [Related]
4. Endothelial SCUBE2 Interacts With VEGFR2 and Regulates VEGF-Induced Angiogenesis.
Lin YC; Chao TY; Yeh CT; Roffler SR; Kannagi R; Yang RB
Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):144-155. PubMed ID: 27834687
[TBL] [Abstract][Full Text] [Related]
5. Endothelial ELABELA improves post-ischemic angiogenesis by upregulating VEGFR2 expression.
Peng JY; Fu X; Luo XY; Liu F; Zhang B; Zhou B; Sun K; Chen AF
Transl Res; 2024 Aug; 270():13-23. PubMed ID: 38548174
[TBL] [Abstract][Full Text] [Related]
6. Naoxintong restores collateral blood flow in a murine model of hindlimb ischemia through PPARδ-dependent mechanism.
Chen L; Zhang L; Fang Z; Li C; Yang Y; You X; Song M; Coffie J; Zhang L; Gao X; Wang H
J Ethnopharmacol; 2018 Dec; 227():121-130. PubMed ID: 30170078
[TBL] [Abstract][Full Text] [Related]
7. Tubeimoside I promotes angiogenesis via activation of eNOS-VEGF signaling pathway.
Yang X; Li X; Luo M; Guo Y; Li C; Lv D; Cheng Z; Huang L; Shang FF; Huang B; Shen J; Luo S; Yan J
J Ethnopharmacol; 2021 Mar; 267():113642. PubMed ID: 33264658
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic angiogenesis of mouse hind limb ischemia by novel peptide activating GRP78 receptor on endothelial cells.
Hardy B; Battler A; Weiss C; Kudasi O; Raiter A
Biochem Pharmacol; 2008 Feb; 75(4):891-9. PubMed ID: 18022603
[TBL] [Abstract][Full Text] [Related]
9. Dapagliflozin Improves Angiogenesis after Hindlimb Ischemia through the PI3K-Akt-eNOS Pathway.
Han L; Ye G; Su W; Zhu Y; Wu W; Hao L; Gao J; Li Z; Liu F; Duan J
Biomolecules; 2024 May; 14(5):. PubMed ID: 38785999
[TBL] [Abstract][Full Text] [Related]
10. Pro-angiogenic activity of notoginsenoside R1 in human umbilical vein endothelial cells in vitro and in a chemical-induced blood vessel loss model of zebrafish in vivo.
Yang BR; Hong SJ; Lee SM; Cong WH; Wan JB; Zhang ZR; Zhang QW; Zhang Y; Wang YT; Lin ZX
Chin J Integr Med; 2016 Jun; 22(6):420-9. PubMed ID: 25533511
[TBL] [Abstract][Full Text] [Related]
11. Oroxyloside inhibits angiogenesis through suppressing internalization of VEGFR2/Flk-1 in endothelial cells.
Zhao K; Li X; Lin B; Yang D; Zhou Y; Li Z; Guo Q; Lu N
J Cell Physiol; 2018 Apr; 233(4):3454-3464. PubMed ID: 28926106
[TBL] [Abstract][Full Text] [Related]
12. Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia.
Ryu J; Lee CW; Hong KH; Shin JA; Lim SH; Park CS; Shim J; Nam KB; Choi KJ; Kim YH; Han KH
Cardiovasc Res; 2008 May; 78(2):333-40. PubMed ID: 18006432
[TBL] [Abstract][Full Text] [Related]
13. Both hydrogen peroxide and transforming growth factor beta 1 contribute to endothelial Nox4 mediated angiogenesis in endothelial Nox4 transgenic mouse lines.
Chen L; Xiao J; Kuroda J; Ago T; Sadoshima J; Cohen RA; Tong X
Biochim Biophys Acta; 2014 Dec; 1842(12 Pt A):2489-99. PubMed ID: 25315297
[TBL] [Abstract][Full Text] [Related]
14. Angiogenic properties of sustained release platelet-rich plasma: characterization in-vitro and in the ischemic hind limb of the mouse.
Bir SC; Esaki J; Marui A; Yamahara K; Tsubota H; Ikeda T; Sakata R
J Vasc Surg; 2009 Oct; 50(4):870-879.e2. PubMed ID: 19679427
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia inducible factor stabilization improves defective ischemia-induced angiogenesis in a rodent model of chronic kidney disease.
Schellinger IN; Cordasic N; Panesar J; Buchholz B; Jacobi J; Hartner A; Klanke B; Jakubiczka-Smorag J; Burzlaff N; Heinze E; Warnecke C; Raaz U; Willam C; Tsao PS; Eckardt KU; Amann K; Hilgers KF
Kidney Int; 2017 Mar; 91(3):616-627. PubMed ID: 27927598
[TBL] [Abstract][Full Text] [Related]
16. Role of simvastatin and/or antioxidant vitamins in therapeutic angiogenesis in experimental diabetic hindlimb ischemia: effects on capillary density, angiogenesis markers, and oxidative stress.
El-Azab MF; Hazem RM; Moustafa YM
Eur J Pharmacol; 2012 Sep; 690(1-3):31-41. PubMed ID: 22705060
[TBL] [Abstract][Full Text] [Related]
17. Adipose stromal cell and sarpogrelate orchestrate the recovery of inflammation-induced angiogenesis in aged hindlimb ischemic mice.
Fan W; Li C; Qin X; Wang S; Da H; Cheng K; Zhou R; Tong C; Li X; Bu Q; Li C; Han Y; Ren J; Cao F
Aging Cell; 2013 Feb; 12(1):32-41. PubMed ID: 23045959
[TBL] [Abstract][Full Text] [Related]
18. The Role of Vascular Endothelial Growth Factor Receptor-1 Signaling in the Recovery from Ischemia.
Amano H; Kato S; Ito Y; Eshima K; Ogawa F; Takahashi R; Sekiguchi K; Tamaki H; Sakagami H; Shibuya M; Majima M
PLoS One; 2015; 10(7):e0131445. PubMed ID: 26133989
[TBL] [Abstract][Full Text] [Related]
19. Angiopoietin-related growth factor enhances blood flow via activation of the ERK1/2-eNOS-NO pathway in a mouse hind-limb ischemia model.
Urano T; Ito Y; Akao M; Sawa T; Miyata K; Tabata M; Morisada T; Hato T; Yano M; Kadomatsu T; Yasunaga K; Shibata R; Murohara T; Akaike T; Tanihara H; Suda T; Oike Y
Arterioscler Thromb Vasc Biol; 2008 May; 28(5):827-34. PubMed ID: 18258819
[TBL] [Abstract][Full Text] [Related]
20. Reduced intracellular chloride concentration impairs angiogenesis by inhibiting oxidative stress-mediated VEGFR2 activation.
Li K; Liu YY; Lv XF; Lin ZM; Zhang TT; Zhang FR; Guo JW; Hong Y; Liu X; Lin XC; Zhou JG; Wu QQ; Liang SJ; Shang JY
Acta Pharmacol Sin; 2021 Apr; 42(4):560-572. PubMed ID: 32694758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
